首页> 外文期刊>Journal of cellular and molecular medicine. >MicroRNA-206 has a bright application prospect in the diagnosis of cases with oral cancer
【24h】

MicroRNA-206 has a bright application prospect in the diagnosis of cases with oral cancer

机译:MicroRNA-206在口服癌病例的诊断中具有明亮的应用前景

获取原文
           

摘要

Previous studies have shown that microRNA-206 ( miR-206 ) exhibits anti-tumour properties in various tumours. Nevertheless, diagnostic significance of miR-206 in oral cancer is still poorly known. Our research was carried out to explore the performance of miR-206 in the diagnosis of oral cancer. Quantitative real-time polymerase chain reaction (qRT-PCR) method was adopted to measure the level of miR-206 in serum specimens from oral cancer cases and control individuals. Chi-square test was performed to analyse the correlation between miR-206 level and clinicopathological parameters of the cases. Receiver operating characteristic (ROC) curve was constituted to assess diagnostic accuracy of miR-206 in oral cancer. Serum miR-206 level in oral cancer patients was significantly lower than that in control individuals ( P ?.001). miR-206 expression was obviously related to T classification ( P =?.033), TNM stage ( P =?.008) and lymph node metastasis ( P =?.028). The area under the curve (AUC) of the ROC curve was 0.846 (95% CI?=?0.797-0.896, P ?.001) with a specificity of 72.7% and a sensitivity of 81.2%. It revealed that miR-206 might be a non-invasive indicator in differentiating oral cancer cases from control individuals. Down-regulation of miR-206 is related to the development of oral cancer. Serum miR-206 might be an effective indicator for early detection of oral cancer.
机译:以前的研究表明,MicroRNA-206(miR-206)在各种肿瘤中表现出抗肿瘤性质。然而,口腔癌中miR-206的诊断意义仍然是令人不难的。我们的研究是为了探讨MIR-206在口腔癌诊断中的表现。采用定量实时聚合酶链反应(QRT-PCR)方法测量口服癌病例和对照个体中血清标本中miR-206的水平。进行Chi-Square试验以分析miR-206水平与病例临床病理参数之间的相关性。接收器操作特征(ROC)曲线被构成,以评估口腔癌中miR-206的诊断准确性。口腔癌患者的血清MIR-206水平明显低于对照个体(P <。001)。 miR-206表达明显与t分类(p = 033),tnm阶段(p =α.008)和淋巴结转移(p = 028)。 ROC曲线的曲线(AUC)下的面积为0.846(95%CI =Δ= 0.797-0.896,p& 001),特异性为72.7%,敏感性为81.2%。揭示MIR-206可能是在对照个体中区分口腔癌病例的非侵入性指标。 miR-206的下调与口腔癌的发育有关。血清miR-206可能是早期检测口腔癌的有效指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号